Blood Processing Devices and Consumables Market Size Analysis:

The Blood Processing Devices and Consumables Market Size was valued at USD 48.3 billion in 2023 and is expected to reach USD 89.41 billion by 2032, growing at a CAGR of 7.11% over the forecast period of 2024-2032.

This report identifies the prevalence and incidence of blood disorders, propelling the demand for sophisticated blood-processing solutions to aid in transfusion and therapy procedures. This study investigates blood donation and transfusion patterns in regions shaped by awareness drives, availability of donors, and healthcare infrastructures. Furthermore, the report analyzes healthcare expenditure on blood processing, as differences in government, commercial, private, and out-of-pocket spending determine market trends. The report explores new technologies and innovations in blood processing, such as automated separation methods and AI-based quality control systems, improving efficiency and safety. Regional regulatory patterns and compliance norms are important influencers of product approvals and manufacturing protocols to maintain safety and efficacy in blood handling processes.

The U.S. Blood Processing Devices and Consumables Market valued at USD 14.23 billion in 2023 and is expected to hit USD 23.82 billion by 2032 at a CAGR of 5.91% over the forecast period of 2024-2032. In the US, rising blood component demand, expanding investments in advanced processing technology, and the stringent FDA rules are fueling market growth, while voluntary blood donation campaigns continue to support supply stability.

Blood Processing Devices and Consumables Market Dynamics

Drivers

• The rising prevalence of blood-related disorders and increasing demand for blood transfusions.

Diseases like anemia, hemophilia, leukemia, and trauma cases have immensely raised the demand for blood-processing equipment. The WHO states that more than 118.5 million blood donations are received worldwide annually, making it necessary to have advanced blood separation and pathogen reduction technologies. Moreover, the growing number of surgeries, organ transplants, and cancer therapies is driving the demand for automated blood processing equipment. The increasing trend towards automated blood management systems is enhancing efficiency and minimizing human errors, further driving market growth. Advances in technology, like next-generation apheresis systems, AI-driven blood analyzers, and disposable blood processing kits, are making the process safer and more accurate. Increasing investments in blood banks and healthcare infrastructure, coupled with government support initiatives towards blood donation awareness, further drive market growth. For instance, the U.S. Department of Health & Human Services' "National Blood Supply" program works towards reinforcing blood banking infrastructures, driving market expansion. Furthermore, mounting anxiety regarding the spread of infectious diseases through blood transfusions has pushed the demand for pathogen reduction technologies at a faster pace, providing safer blood supply chains and propelling the demand for quality blood processing equipment.

Restraints

• High cost of blood processing devices and consumables, limiting their adoption, especially in low-income and developing regions.

High-tech blood processing equipment, including automated apheresis systems and pathogen reduction technologies, is priced between USD 30,000 and USD 100,000, which makes them economically infeasible for most healthcare institutions. The lack of skilled personnel in blood banking and transfusion medicine also holds back market expansion as these systems need to be used with expert training. Regulatory complexities are also a significant challenge, with complex approval processes of organizations like the FDA, EMA, and WHO, which postpone product launches. Further, limited reimbursement policies for blood transfusions and processing procedures impose economic burdens on hospitals and diagnostic laboratories, inhibiting their investment in sophisticated equipment. The threat of blood contamination and waste associated with ineffective storage and processing technologies continues to pose a challenge, necessitating higher compliance standards. In addition, the dependency on voluntary donations that tend to change with demographic and seasonal factors influences the supply of blood products, restricting the requirement for processing tools. All these aspects cumulatively limit the scalability and reach of blood processing technologies, particularly in resource-scarce healthcare environments.

Opportunities

• The growing focus on automation and AI-driven blood processing solutions presents significant opportunities for market expansion.

Automated blood processing equipment minimizes human errors, improving efficiency and enhancing the safety of blood products overall. The use of artificial intelligence-based hematology analyzers and intelligent blood storage systems is optimizing processes, accelerating tasks, and reducing costs. Moreover, growing needs for individualized medicine and cell therapy are pushing innovation in blood component separation and stem cell processing, with new revenue opportunities. The growth of point-of-care blood processing technology, especially in acute and remote care areas, represents significant growth prospects. Businesses are making investments in portable and compact blood processing tools for the acceleration of blood tests and transfusions away from their usual hospital surroundings. Additionally, collaborations among blood banks, biotech companies, and healthcare operators are improving development and research activities for next-generation blood processing devices. The growing demand for sustainable and environmentally friendly blood processing consumables, including biodegradable blood bags and non-toxic anticoagulants, represents another emerging trend. In addition, government-driven initiatives for universal blood screening and safety regulations will be expected to propel the usage of sophisticated processing technologies, assuring long-term market expansion.

Challenges

• One of the biggest challenges in the market is the global shortage of blood donations, which directly impacts the demand for blood-processing devices.

Even with WHO efforts to promote voluntary blood donation, several regions continue to have severe shortages, resulting in unmet transfusion requirements. Moreover, the market has logistical and supply chain issues in ensuring the cold chain and appropriate storage conditions for blood products, particularly in low-resource environments. The threat of transfusion-transmissible infections (TTIs), including HIV, hepatitis, and bacterial contamination, is a serious issue, requiring rigorous blood screening practices. Yet, the deployment of these screening procedures involves heavy investments in infrastructure and compliance, which is a strain on small healthcare facilities. The other significant challenge is the standardization of blood processing methods across regions since regulatory guidelines are extremely diverse across countries. This diversity makes product approvals and market entry strategies for device manufacturers complicated. Additionally, the growing cybersecurity risks within automated blood banking systems threaten data breaches, affecting patient safety and business efficiency. The resolution of these issues will involve joint efforts by regulatory authorities, healthcare organizations, and technology innovators to implement safer, more efficient blood-processing technology globally.

Blood Processing Devices and Consumables Market Segmentation Analysis

By Product

Devices dominated the share of the blood processing devices and consumables market, with 56.8% of all revenue in 2023. The leadership of devices is fueled by the extensive use of automated blood processing technologies such as centrifuges, apheresis devices, and leukoreduction filters. The rising need for effective blood separation, pathogen reduction, and component storage solutions has driven market growth. Furthermore, blood banks and hospitals are making investments in sophisticated equipment for blood processing to increase the safety of transfusions and reduce wastage.

Consumables are estimated to exhibit the highest growth during the forecast period as a result of increasing demand for disposable blood bags, reagents, collection tubes, and filtration kits. The growing rates of blood donations and transfusions, combined with stringent infection control policies, are contributing to the increasing demand for single-use consumables. Furthermore, the cost-effectiveness and simplicity of the replacement of consumables in blood banks and healthcare centers also bolster market growth.

By End Use

Hospitals and clinics dominated the market in 2023, with the largest revenue share, owing to the significant number of blood transfusions, surgeries, and emergency procedures that necessitate blood components. Advanced blood processing infrastructure existing within the country, combined with more patient admissions for chronic diseases and trauma cases, accounted for the dominance of the segment. Moreover, hospitals are the central point of care for critical conditions such as cancer, anemia, and hemophilia, further reaffirming their market position.

Diagnostic laboratories are forecasted to increase at the most rapid pace as a result of increasing demand for blood-based diagnostics, growing incidence of infectious diseases, and hematology testing advancements. The use of automated blood analyzers, molecular diagnostics, and point-of-care testing is broadening laboratory services, which contributes to higher market penetration. In addition, the drive towards preventive care and early disease diagnosis is energizing demand for blood processing consumables and devices used in the diagnostic environment.

Blood Processing Devices and Consumables Market Regional Insights

North America led the blood processing devices and consumables market with revenue share of around 39% in 2023, fueled by sophisticated healthcare facilities, superior blood donation rates, and enormous investments in blood safety devices. The country with the most leading position is the U.S., aided by national programs like the American Red Cross and AABB (Association for the Advancement of Blood & Biotherapies) that have strong adherence to blood processing standards. Furthermore, the region is aided by the presence of leading industry players and high penetration levels of automated blood processing systems. Europe ranks second due to stringent regulatory structures, established blood banking infrastructures, and growing demand for pathogen-reduced blood components.

Asia-Pacific is the most rapidly expanding region, propelled by escalating investments in healthcare, increasing awareness about blood donation, and the growing prevalence of chronic conditions. China, India, and Japan are experiencing high demand for blood processing consumables because of growing hospital infrastructure and a rise in the number of surgeries and transfusions. The Asia-Pacific market for blood processing is likely to experience double-digit growth, driven by government-sponsored blood donation campaigns and advances in blood storage and separation methods. Additionally, the increasing incidence of blood disorders like thalassemia and hemophilia is also driving market growth in the region.

Key Players and Their Blood Processing Devices & Consumables

• bioMérieux SA – BACT/ALERT Blood Culture System, VIDAS Immunoassay Blood Screening

• Abbott – ARCHITECT i1000SR & i2000SR Immunoassay Analyzers, Alinity s System for Blood & Plasma Screening

• Bio-Rad Laboratories, Inc. – IH-500 & IH-1000 Blood Typing Analyzers, D-10 Hemoglobin Testing System

• BD (Becton, Dickinson and Company) – BD Vacutainer Blood Collection Tubes, BD BACTEC Blood Culture System

• F. Hoffmann-La Roche Ltd – cobas 6800/8800 Blood Screening Systems, Accu-Chek Blood Glucose Monitoring

• Danaher Corporation – Beckman Coulter DxH 900 Hematology Analyzer, Leica Biosystems Pathology Solutions

• Immucor, Inc. – Echo Lumena Blood Typing System, NEO Iris Blood Bank Analyzer

• ThermoGenesis Holdings, Inc. – AXP II Automated Cell Processing System, BioArchive Smart Cryopreservation System

• Grifols, S.A. – Procleix Panther Blood Screening System, Erytra Automated Blood Typing System

• Terumo Corporation – Spectra Optia Apheresis System, Terumo Blood Bags & Blood Collection Sets

• Haemonetics Corporation – MCS+ Apheresis System, NexSys PCS Plasma Collection System

• Macopharma – Leucoflex Leukoreduction Filters, Macopress Smart Blood Component Separator

Recent Developments in the Blood Processing Devices and Consumables Market

• In Feb 2025, Tasso, Inc. introduced its next-generation dried blood spot (DBS) sample collection technology, featuring the Tile-T20 dried whole blood cartridge integrated with the Tasso Mini device. This innovation enhances the accuracy and convenience of DBS collection, catering to clinical trials and sports anti-doping testing.

• In March 2024, the FDA granted 510(k) clearance to RedDrop Dx for its RedDrop One blood collection device. This innovative device enables the collection of larger blood volumes with enhanced reliability, improving efficiency in blood sampling and diagnostics.